Zosano Pharma (ZSAN) Stock Up 75%: Should You Buy & Hold It?

February 09, 2021 12:35 AM PST | By Team Kalkine Media
 Zosano Pharma (ZSAN) Stock Up 75%: Should You Buy & Hold It?

Summary

  • Stocks of pharmaceutical company Zosano Pharma Corp (NASDAQ:ZSAN, ZSAN:US) shot up by over 75 per cent on Monday, February 8.
  • While there were no clear business or corporate news from the company, some media outlets reported on Monday that Zosano Pharma stocks have received positive ratings from Wall Street analysts.
  • The shares also noted a sharp jump last week (February 1) after Zosano announced submitting the early onset of action data of its investigational migraine therapy at a winter conference.

Stocks of pharmaceutical company Zosano Pharma Corp (NASDAQ:ZSAN, ZSAN:US) shot up by over 75 per cent on Monday, February 8. The latest surge inflates the pharma stock by over 266 per cent year-to-date and by almost 110 per cent in February.

Let’s take a closer look at Zosano’s profile to under the latest jump in its stock price and its recent performance in general.

 

Zosano Pharma Corp (NASDAQ:ZSAN, ZSAN:US)

Current Stock Price: US$ 1.93


While there were no clear business or corporate news from the company, some media outlets reported on Monday that Zosano Pharma stocks have received positive ratings from Wall Street analysts.

The shares also noted a sharp jump last week (February 1) after Zosano announced submitting the early onset of action data of its investigational migraine therapy at a winter conference. The pharma company said that its alternative therapy using microneedle system, named Qtrypta™, has “tremendous potential” to acutely treat migraine.

Zosano stocks, which gained about 135 per cent in the last one year, saw over 12.7 million shares exchange hands over the last 10 days. Its one-month share trading volume stands at 12.5 million.

©Kalkine Group 2020

The clinical-stage biopharmaceutical firm currently holds a market cap of nearly US$ 197 million, with a price-to-book (P/B) ratio of 3.57 and a debt-to-equity (D/E) ratio of 0.32, as per the data available on the TMX Group portal.

On the financial front, Zosano saw a year-over-year (YoY) reduction in its net loss for the third quarter of 2020, down to US$ 8.7 million from that of US$ 9.9 million in Q3 2019. Its cash and cash equivalents amounted to a total of US$ 43.6 million at the end of 30 September 2020, significantly up from that of US$ 6.3 million at December-end in 2019.

Some Wall Street analysts reportedly expect Zosano stock to surge significantly over the next 12 months, which makes it an attractive buy. Nonetheless, investors should do their own enhanced research before making any investment decisions.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media LLC (Kalkine Media, we or us) and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures/music displayed/used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it, as necessary.


Sponsored Articles


Investing Ideas

Previous Next